| phosphodiesterase 4A, cAMP specific |
GENISTEIN |
Phosphodiesterase PDE4 |
74% |
10.924uM |
NoneNone |
View
|
| phosphodiesterase 4C, cAMP-specific |
GENISTEIN |
Phosphodiesterase PDE4 |
74% |
10.924uM |
NoneNone |
View
|
| phosphodiesterase 4D |
GENISTEIN |
Phosphodiesterase PDE4 |
74% |
10.924uM |
NoneNone |
View
|
| phosphodiesterase 4B, cAMP specific |
GENISTEIN |
Phosphodiesterase PDE4 |
74% |
10.924uM |
NoneNone |
View
|
| A3 adenosine receptor |
ISOTRETINOIN |
Adenosine A3 |
74% |
4.169uM |
2.357uM |
View
|
| Sigma-2 Receptor |
VERAPAMIL |
Sigma2 |
74% |
2.824uM |
1.738uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
GUANFACINE |
Serotonin 5-HT2B |
74% |
2.098uM |
1.335uM |
View
|
| adrenergic receptor, alpha 1b |
CITALOPRAM |
Adrenergic alpha1B |
74% |
3.288uM |
1.82uM |
View
|
| adrenergic receptor, alpha 2a |
MEPAZINE |
Adrenergic alpha2A |
74% |
1.456uM |
.546uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
LOPERAMIDE |
Serotonin Transporter |
74% |
2.202uM |
1.17uM |
View
|
| adrenergic receptor, alpha 1a |
LOPERAMIDE |
Adrenergic alpha1A |
74% |
6.219uM |
2.517uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
SERTRALINE |
Calcium Channel Type L, Benzothiazepine |
74% |
1.468uM |
1.3049uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
SERTRALINE |
Calcium Channel Type L, Benzothiazepine |
74% |
1.468uM |
1.3049uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
SERTRALINE |
Calcium Channel Type L, Benzothiazepine |
74% |
1.468uM |
1.3049uM |
View
|
| sodium channel associated protein 1 |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel associated protein 2 |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type III, beta |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| amiloride-sensitive cation channel 5, intestinal |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type III, beta |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type I, beta |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type II, beta |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, nonvoltage-gated 1 beta |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, nonvoltage-gated 1, delta |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type X, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage gated, type VIII, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type IV, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type III, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type II, beta |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type I, beta |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| cholinergic receptor, muscarinic 5 |
BETAMETHASONE PHOSPHATE |
Muscarinic M5 |
74% |
7.861uM |
5.648uM |
View
|
| adrenergic receptor, alpha 2b |
TERAZOSIN |
Adrenergic alpha2C |
74% |
6.042uM |
.878uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
TERAZOSIN |
Adrenergic alpha2C |
74% |
6.042uM |
.878uM |
View
|
| tachykinin receptor 1 |
TAMOXIFEN |
Tachykinin NK1 |
74% |
15.656uM |
8.54uM |
View
|
| dopamine receptor D4 |
TAMOXIFEN |
Dopamine D4.2 |
74% |
11.161uM |
3.913uM |
View
|
| adenosine A1 receptor |
TAMOXIFEN |
Adenosine A1 |
74% |
23.767uM |
13.864uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| mitogen-activated protein kinase 3 |
HYDROXYPROGESTERONE |
Protein Serine/Threonine Kinase, ERK1 |
74% |
3.157uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
NIFEDIPINE |
Calcium Channel Type L, Phenylalkylamine |
74% |
.878uM |
.853uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
CISAPRIDE |
Serotonin 5-HT1A |
74% |
2.829uM |
1.617uM |
View
|
| phosphodiesterase 4A, cAMP specific |
DIPYRIDAMOLE |
Phosphodiesterase PDE4 |
74% |
1.579uM |
NoneNone |
View
|
| potassium voltage-gated channel, subfamily H, member 8 |
CARVEDILOL |
Potassium Channel HERG |
74% |
4.1193uM |
3.3749uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 6 |
CARVEDILOL |
Potassium Channel HERG |
74% |
4.1193uM |
3.3749uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 7 |
CARVEDILOL |
Potassium Channel HERG |
74% |
4.1193uM |
3.3749uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 2 |
CARVEDILOL |
Potassium Channel HERG |
74% |
4.1193uM |
3.3749uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 5 |
CARVEDILOL |
Potassium Channel HERG |
74% |
4.1193uM |
3.3749uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 3 |
CARVEDILOL |
Potassium Channel HERG |
74% |
4.1193uM |
3.3749uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 4 |
CARVEDILOL |
Potassium Channel HERG |
74% |
4.1193uM |
3.3749uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 1 |
CARVEDILOL |
Potassium Channel HERG |
74% |
4.1193uM |
3.3749uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 1 |
CARVEDILOL |
Potassium Channel HERG |
74% |
4.1193uM |
3.3749uM |
View
|
| Sigma-2 Receptor |
BUPROPION |
Sigma2 |
74% |
2.3156uM |
1.425uM |
View
|
| cholinergic receptor, muscarinic 4 |
PERHEXILINE |
Muscarinic M4 |
74% |
3.5919uM |
.5009uM |
View
|
| 5-hydroxytryptamine receptor 6 |
DESLORATADINE |
Serotonin 5-HT6 |
74% |
2.171uM |
1.008uM |
View
|
| 5-hydroxytryptamine receptor 6 |
METHAPYRILENE |
Serotonin 5-HT6 |
74% |
3.091uM |
1.435uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
MONTELUKAST |
Serotonin 5-HT2B |
74% |
6.256uM |
3.981uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
IMATINIB |
Serotonin 5-HT2A |
74% |
1.891uM |
.54uM |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
IODOQUINOL |
Protein Tyrosine Kinase, HER2 Receptor |
74% |
8.577uM |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
IODOQUINOL |
Protein Tyrosine Kinase, HER2 Receptor |
74% |
8.577uM |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
HYDROXYPROGESTERONE |
Protein Serine/Threonine Kinase, ERK1 |
74% |
3.157uM |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
BERBERINE CHLORIDE |
CYP450-2D6 Inhibition |
74% |
4.5042uM |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
CLOMIPHENE |
CYP450-2D6 Inhibition |
74% |
10uM |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
CILOSTAZOL |
CYP450-2C9 Inhibition |
74% |
10uM |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
CILOSTAZOL |
CYP450-2C9 Inhibition |
74% |
10uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
CLOSANTEL |
Adrenergic alpha2B |
74% |
1.8uM |
.8219uM |
View
|
| adrenergic receptor, alpha 2b |
DOBUTAMINE |
Adrenergic alpha2B |
74% |
2.966uM |
1.354uM |
View
|
| endothelin receptor type A |
GRAMICIDIN |
Endothelin ETA |
74% |
2.983uM |
1.835uM |
View
|
| dopamine receptor D1A |
ABAMECTIN |
Dopamine D1 |
74% |
6.119uM |
3.06uM |
View
|
| adrenergic receptor, beta 1 |
ERGOTAMINE |
Adrenergic beta1 |
74% |
4.142uM |
2.392uM |
View
|
| adrenergic, beta-1-, receptor |
ERGOTAMINE |
Adrenergic beta1 |
74% |
4.142uM |
2.392uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
DIHYDROERGOCRISTINE MESYLATE |
Serotonin 5-HT4 |
74% |
4.912uM |
.819uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
DIHYDROERGOCRISTINE MESYLATE |
Serotonin 5-HT4 |
74% |
4.912uM |
.819uM |
View
|
| cholinergic receptor, muscarinic 5 |
QUETIAPINE |
Muscarinic M5 |
74% |
3.0007uM |
2.1559uM |
View
|
| adrenergic receptor, alpha 2a |
QUETIAPINE |
Imidazoline I2, Central |
74% |
1.5211uM |
1.0141uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
QUETIAPINE |
Imidazoline I2, Central |
74% |
1.5211uM |
1.0141uM |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
NELFINAVIR |
CYP450-3A4 Inhibition |
74% |
2uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1b |
SILDENAFIL |
Adrenergic alpha1B |
74% |
1.457uM |
.806uM |
View
|
| adrenergic receptor, alpha 2a |
PENTAMIDINE |
Imidazoline I2, Central |
74% |
3.524uM |
2.349uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
PENTAMIDINE |
Imidazoline I2, Central |
74% |
3.524uM |
2.349uM |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
PIOGLITAZONE |
Aldose Reductase |
74% |
13.2uM |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
PIOGLITAZONE |
Aldose Reductase |
74% |
13.2uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
PIOGLITAZONE |
Aldose Reductase |
74% |
13.2uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
PIOGLITAZONE |
Aldose Reductase |
74% |
13.2uM |
NoneNone |
View
|
| monoamine oxidase A |
ETHYNODIOL DIACETATE |
Monoamine Oxidase MAOA |
74% |
4.29uM |
NoneNone |
View
|
| monoamine oxidase A |
ETHYNODIOL DIACETATE |
Monoamine Oxidase MAOA |
74% |
4.29uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
SULPIRIDE |
Adrenergic alpha2A |
74% |
2.019uM |
.757uM |
View
|
| cholinergic receptor, muscarinic 5 |
PIPAMAZINE |
Muscarinic M5 |
74% |
3.144uM |
2.259uM |
View
|
| melanocortin 5 receptor |
MICONAZOLE |
Melanocortin MC5 |
74% |
22.607uM |
21.206uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
KETOCONAZOLE |
Dopamine Transporter |
74% |
23.517uM |
18.685uM |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
INDOMETHACIN |
Aldose Reductase |
74% |
3.631uM |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
INDOMETHACIN |
Aldose Reductase |
74% |
3.631uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
INDOMETHACIN |
Aldose Reductase |
74% |
3.631uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
INDOMETHACIN |
Aldose Reductase |
74% |
3.631uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1b |
DESLORATADINE |
Adrenergic alpha1B |
74% |
3.623uM |
2.005uM |
View
|
| mitogen activated protein kinase 14 |
4-OCTYLPHENOL |
Protein Serine/Threonine Kinase, p38alpha |
74% |
15.016uM |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
4-OCTYLPHENOL |
Protein Serine/Threonine Kinase, p38alpha |
74% |
15.016uM |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
3-METHYLCHOLANTHRENE |
Protein Tyrosine Kinase, Fyn |
74% |
25.177uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
AMITRIPTYLINE |
Serotonin 5-HT1B |
74% |
3.73uM |
1.695uM |
View
|
| Cytochrom P450-2C19 monooxygenase |
CLOTRIMAZOLE |
CYP450-2C19 Inhibition |
74% |
.016uM |
NoneNone |
View
|
| cholinergic receptor, muscarinic 2 |
AMIODARONE |
Muscarinic M2 |
74% |
5.08uM |
1.806uM |
View
|
| A3 adenosine receptor |
AMIODARONE |
Adenosine A3 |
74% |
17.547uM |
9.918uM |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
TROPICAMIDE |
CYP450-2C9 Inhibition |
74% |
1uM |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
TROPICAMIDE |
CYP450-2C9 Inhibition |
74% |
1uM |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
ACONITINE |
Sodium Channel, Site 2 |
74% |
4.49uM |
4.096uM |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
OXYMETAZOLINE |
Sodium Channel, Site 2 |
73% |
3.45uM |
3.148uM |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
OXYMETAZOLINE |
Sodium Channel, Site 2 |
73% |
3.45uM |
3.148uM |
View
|
| sodium channel, voltage-gated, type II, beta |
OXYMETAZOLINE |
Sodium Channel, Site 2 |
73% |
3.45uM |
3.148uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
ORPHENADRINE |
Adrenergic, Norepinephrine Transporter |
73% |
2.666uM |
2.643uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
EBASTINE |
Serotonin Transporter |
73% |
1.2287uM |
.6528uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
DOMPERIDONE |
Adrenergic, Norepinephrine Transporter |
73% |
2.614uM |
2.593uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
PROMETHAZINE |
Serotonin Transporter |
73% |
4.01uM |
2.13uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
CETYLPYRIDINIUM BROMIDE |
Dopamine Transporter |
73% |
6.279uM |
4.989uM |
View
|
| dopamine receptor D1A |
PROMETHAZINE |
Dopamine D1 |
73% |
2.744uM |
1.372uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
LACIDIPINE |
Adrenergic, Norepinephrine Transporter |
73% |
5.735uM |
5.687uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
RALOXIFENE |
Serotonin Transporter |
73% |
3.576uM |
1.9uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
DAPIPRAZOLE |
Serotonin 5-HT1A |
73% |
2.06uM |
1.177uM |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
BENZETHONIUM CHLORIDE |
Protein Tyrosine Kinase, HER2 Receptor |
73% |
2.084uM |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
BENZETHONIUM CHLORIDE |
Protein Tyrosine Kinase, HER2 Receptor |
73% |
2.084uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PHENTOLAMINE |
Calcium Channel Type L, Phenylalkylamine |
73% |
.746uM |
.725uM |
View
|
| Cytochrom P450-1A2 monooxygenase |
SB-203580 |
CYP450-1A2 Inhibition |
73% |
2uM |
NoneNone |
View
|
| adrenergic receptor, beta 2 |
DOXAZOSIN |
Adrenergic beta2 |
73% |
2.748uM |
1.889uM |
View
|
| 5-hydroxytryptamine receptor 6 |
HALOPROGIN |
Serotonin 5-HT6 |
73% |
4.011uM |
1.862uM |
View
|
| phosphodiesterase 4A, cAMP specific |
CLADRIBINE |
Phosphodiesterase PDE4 |
73% |
3.625uM |
NoneNone |
View
|
| phosphodiesterase 4C, cAMP-specific |
CLADRIBINE |
Phosphodiesterase PDE4 |
73% |
3.625uM |
NoneNone |
View
|
| phosphodiesterase 4D |
CLADRIBINE |
Phosphodiesterase PDE4 |
73% |
3.625uM |
NoneNone |
View
|
| phosphodiesterase 4B, cAMP specific |
CLADRIBINE |
Phosphodiesterase PDE4 |
73% |
3.625uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
THIMEROSAL |
Adrenergic alpha2C |
73% |
5.041uM |
.732uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
THIMEROSAL |
Adrenergic alpha2C |
73% |
5.041uM |
.732uM |
View
|
| A3 adenosine receptor |
BENZBROMARONE |
Adenosine A3 |
73% |
5.222uM |
2.952uM |
View
|
| arachidonate 15-lipoxygenase, second type |
DIPYRIDAMOLE |
Lipoxygenase 15-LO |
73% |
6.956uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase |
DIPYRIDAMOLE |
Lipoxygenase 15-LO |
73% |
6.956uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase |
DIPYRIDAMOLE |
Lipoxygenase 15-LO |
73% |
6.956uM |
NoneNone |
View
|
| estrogen receptor 1 |
CAFFEIC ACID PHENETHYL ESTER |
Estrogen ERalpha |
73% |
7.912uM |
2.26uM |
View
|
| estrogen receptor 1 |
CAFFEIC ACID PHENETHYL ESTER |
Estrogen ERalpha |
73% |
7.912uM |
2.26uM |
View
|
| dopamine receptor D1A |
DOXEPIN |
Dopamine D1 |
73% |
.688uM |
.344uM |
View
|
| opioid receptor, sigma 1 |
DOXEPIN |
Sigma1 |
73% |
.631uM |
.265uM |
View
|
| Cytochrom P450-2E1 monooxygenase |
CARBON TETRACHLORIDE |
CYP450-2E1 Inhibition |
73% |
11uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
HALOPERIDOL |
Adrenergic alpha2A |
73% |
4.973uM |
1.865uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
HALOPERIDOL |
Serotonin 5-HT2C |
73% |
3.347uM |
1.753uM |
View
|
| histamine receptor H 1 |
HALOPERIDOL |
Histamine H1, Central |
73% |
2.781uM |
.323uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
MONOBENZONE |
Adrenergic, Norepinephrine Transporter |
73% |
3.886uM |
3.854uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
VERAPAMIL |
Serotonin 5-HT1A |
73% |
3.02uM |
1.726uM |
View
|
| Cytochrom P450-1A2 monooxygenase |
1-NAPHTHYL ISOTHIOCYANATE |
CYP450-1A2 Inhibition |
73% |
1uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
TIAPRIDE |
Adrenergic alpha2A |
73% |
2.078uM |
.779uM |
View
|